Su-kyeong W. Hwang
Daegu, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Safety and efficacy of AST-001 in children with autism spectrum disorder: a 52-week multicenter long-term follow-up study.
Journal: Frontiers in psychiatry
Published: January 09, 2026
Integrated proteomic and single-cell transcriptomic profiling elucidates immunomodulatory effects of L-serine in autism spectrum disorder.
Journal: Scientific reports
Published: October 14, 2025
Response to [Examining the feasibility and limitations of AST-001 as a treatment for autism spectrum disorder].
Journal: Psychiatry and clinical neurosciences
Published: January 02, 2025
Population pharmacokinetic and pharmacodynamic model guided weight-tiered dose of AST-001 in pediatric patients with autism spectrum disorder.
Journal: Frontiers in pharmacology
Published: June 21, 2024
AST-001 versus placebo for social communication in children with autism spectrum disorder: A randomized clinical trial.
Journal: Psychiatry and clinical neurosciences
Published: March 08, 2024
L-serine restored lysosomal failure in cells derived from patients with BPAN reducing iron accumulation with eliminating lipofuscin.
Journal: Free radical biology & medicine
Published: February 13, 2024
AST-001 Improves Social Deficits and Restores Dopamine Neuron Activity in a Mouse Model of Autism.
Journal: Biomedicines
Published: November 14, 2023
Changes of lysosome by L-serine in rotenone-treated hippocampal neurons.
Journal: Applied microscopy
Published: October 21, 2022
Sirtuin 3 mutation- induced mitochondrial dysfunction and optic neuropathy: a case report.
Journal: BMC ophthalmology
Published: August 26, 2022
Restoration of Cathepsin D Level via L-Serine Attenuates PPA-Induced Lysosomal Dysfunction in Neuronal Cells.
Journal: International journal of molecular sciences
Published: July 29, 2022
Last Updated: 09/26/2026